The treatment with pNAPE-LP significantly ameliorated the colitis histopathological score and decreased MPO activity in comparison to DSS-treated mice (Figure 2E–G, 3.83 ± 0.95, 13.4 ± 4.16; p ˂ 0.001 vs. DSS). This evidence concerns the gene MPO and colitis.